Open in Screener

JNJ

Johnson & Johnson

Apr 02 • 04:00PM ET

243.04

-1.08 -0.44 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK PFE NVS AMGN BMY LLY GSK ABT MDT SYK

| Held by: VTI VOO IVV SPY VTV XLV VIG VYM VHT DIA

Index	DJIA, S&P 500	P/E	22.00	EPS (ttm)	11.05	Insider Own	0.13%	Shs Outstand	2.41B	Perf Week	1.59%
Market Cap	585.39B	Forward P/E	19.33	EPS next Y	12.57	Insider Trans	-10.32%	Shs Float	2.41B	Perf Month	-0.92%
Enterprise Value	614.62B	PEG	2.29	EPS next Q	2.69	Inst Own	74.80%	Short Float	0.97%	Perf Quarter	17.44%
Income	26.80B	P/S	6.22	EPS this Y	7.11%	Inst Trans	0.66%	Short Ratio	2.63	Perf Half Y	30.63%
Sales	94.19B	P/B	7.18	EPS next Y	8.77%	ROA	14.13%	Short Interest	23.33M	Perf YTD	17.44%
Book/sh	33.86	P/C	29.12	EPS next 5Y	8.43%	ROE	35.03%	52W High	251.71 -3.44%	Perf Year	56.44%
Cash/sh	8.35	P/FCF	29.72	EPS past 3/5Y	17.88% 14.90%	ROIC	21.90%	52W Low	141.50 71.76%	Perf 3Y	56.80%
Dividend Est.	5.29 (2.18%)	EV/EBITDA	18.55	Sales past 3/5Y	5.56% 2.67%	Gross Margin	67.97%	Volatility	1.55% 1.74%	Perf 5Y	49.26%
Dividend TTM	5.20 (2.14%)	EV/Sales	6.53	EPS Y/Y TTM	90.55%	Oper. Margin	27.21%	ATR (14)	4.08	Perf 10Y	122.58%
Dividend Ex-Date	Feb 24, 2026	Quick Ratio	0.77	Sales Y/Y TTM	6.05%	Profit Margin	28.46%	RSI (14)	56.97	Recom	2.10
Dividend Gr. 3/5Y	4.92% 5.25%	Current Ratio	1.03	EPS Q/Q	48.39%	SMA20	1.07%	Beta	0.34	Target Price	246.70
Payout	46.59%	Debt/Eq	0.60	Sales Q/Q	9.07%	SMA50	1.73%	Rel Volume	0.77	Prev Close	244.12
Employees	140800	LT Debt/Eq	0.50	Earnings	Apr 14 BMO	SMA200	22.49%	Avg Volume	8.86M	Price	243.04
IPO	Sep 25, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.12% 1.72%	Trades		Volume	6,864,691	Change	-0.44%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$262
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$230
Oct-20-25	Upgrade	Daiwa Securities	Neutral → Outperform	$203
Oct-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$212
Sep-23-25	Upgrade	Guggenheim	Neutral → Buy	$206
Jul-23-25	Upgrade	Erste Group	Hold → Buy
May-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$153
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170

Show Previous Ratings

Apr-03-26 09:30AM	Alphabet vs. Tesla: This stock is just an 'immense cash flow machine' (Yahoo Finance Video)
Apr-02-26 03:39PM	Trump Slaps 100% Tariffs on Some Drug Imports. What to Know. (Barrons.com)
08:01AM	JNJ Stocks 60% Breakout: Why Wall Street is Torn (Trefis)
Mar-31-26 03:45PM	$2 Billion Bayer Verdict: What the Roundup Decision Means for MAHA (Exec Edge)
12:54PM	Why Johnson & Johnson Is Rebounding - Finally (Investor's Business Daily)
06:30AM	Loading…
06:30AM	Can Boston Scientific Stock Surge 40% From Here? (Trefis)
Mar-28-26 10:00AM	ICOTYDE (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis (PR Newswire)
Mar-27-26 12:58PM	J&Js Darzalex nets first self-administered cancer injectable approval (Pharmaceutical Technology)
Mar-25-26 01:10PM	Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets (Barrons.com)
Mar-20-26 08:00AM	After notable victories, anti-DEI shareholders turn sights on Trump's SEC (Financial Planning)
07:19AM	Origin Materials and HP Embalagens enter PET cap distribution deal (Packaging Gateway)
Mar-18-26 02:29PM	Analysis-TrumpRx lists many medicines at prices higher than paid in UK (Reuters)
10:48AM	Have Amazon and Nvidia become value stocks? This metric says yes. (MarketWatch)
08:05AM	J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections (BioPharma Dive)
07:49AM	FDA approval of ICOTYDE (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide (PR Newswire)
06:11AM	Loading…
06:11AM	Crossbow raises $77M for new cancer immunotherapies (BioPharma Dive)
Mar-17-26 10:00AM	Dow Jones opens higher with IBM, Goldman Sachs leading, as Iran strikes continue (Proactive)
Mar-13-26 12:35PM	Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer (PR Newswire)
Mar-12-26 08:00AM	Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients (Business Wire)
Mar-11-26 07:00AM	Stanford Grads Tampon Startup Takes on Growing Market (Sportico)
07:00AM	Ex-Stanford Athletes Tampon Startup Takes on Growing Market (Sportico)
05:25AM	Johnson & Johnson price target raised to $274 from $250 at Citi (TipRanks)
05:20AM	Coloplast names former J&J executive Gavin Wood as CEO (MedTech Dive)
03:10AM	Enter the shark tank: How Kenvue innovates its operations (Supply Chain Dive)
Mar-10-26 01:59PM	FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder (Benzinga)
11:31AM	JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer (Zacks)
08:37AM	What Drives Hologic's GYN Surgical Strength in a Competitive Market? (Zacks)
07:15AM	Johnson & Johnson (JNJ) Units to Pay $65 Million in Tracleer Antitrust Class Action Settlement, Reuters Reports (Insider Monkey)
04:38AM	Johnson & Johnson (JNJ) Announces the FDA Approval of TECVAYLI plus DARZALEX FASPRO (Insider Monkey)
Mar-09-26 01:42PM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
10:18AM	Loading…
10:18AM	Stock Market Today: Dow Dives As Oil Prices Surge On Iran War; Transport Stocks Knife Lower (Live Coverage) (Investor's Business Daily)
08:10AM	Quiet Outperformance From an Overlooked Dividend ETF (MarketBeat)
Mar-08-26 12:50PM	Johnson and Johnson (JNJ) Reports Positive Phase 1b Cancer Data (Insider Monkey)
09:54AM	Retirees Take Note: DGRO Yields 2.4%, Has Raised Its Dividend Every Single Year for Over a Decade (24/7 Wall St.)
Mar-06-26 09:25PM	BofA Boosts Johnson & Johnson (JNJ) Price Target as Pipeline Outlook Improves (Insider Monkey)
04:01PM	Jobs Crash, War Flares: Smart Money Hides In These Stocks (Benzinga)
03:48PM	Jobs Report Just Dented Most Bulletproof Sector ETF In The Market (Benzinga)
11:30AM	Lilly (LLY) Down 3.7% Since Last Earnings Report: Can It Rebound? (Zacks)
10:27AM	Google Grabs Attention, But Funds Go Crazy For This 'Pick-And-Shovel' AI Stock (Investor's Business Daily)
08:53AM	FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results (Benzinga)
08:43AM	The 5 Safest Dividend Kings Have Raised Their Dividends for Over 50 Years (24/7 Wall St.)
08:02AM	Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last (24/7 Wall St.)
07:39AM	Will AbbVie's Neuroscience Segment Continue to Aid Top Line in 2026? (Zacks)
Mar-05-26 05:45PM	Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors (Zacks)
03:55PM	Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI plus DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line (PR Newswire)
11:30AM	Pfizer (PFE) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
10:25AM	Dow slides more than 550 points to set session low (MarketWatch)
09:55AM	Dow Jones opens lower but Nasdaq flat as Broadcom gains (Proactive)
09:30AM	Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion (PR Newswire)
08:45AM	Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations? (Zacks)
Mar-04-26 11:35AM	When Fear Hits the Stock Market, Where Can Investors Find Safety? (Barchart)
11:31AM	Top 3 Dividend Aristocrat Stocks to Buy for Strong Returns in 2026 (24/7 Wall St.)
11:02AM	Bayer Q4 Earnings Match Estimates, Xarelto and Eylea Pull Down Sales (Zacks)
09:00AM	Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-03-26 11:04AM	Retire Comfortably With These Dividend Growth Stocks (24/7 Wall St.)
09:10AM	Immunology, Neuroscience Step Up as Key Growth Engines for J&J (Zacks)
08:03AM	Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE) (PR Newswire)
04:46AM	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer (Zacks)
03:29AM	Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference (MarketBeat)
03:00AM	J&Js blockbuster Spravato is setting the stage for managing psychedelics risks (Pharma Voice)
Mar-02-26 06:50PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
04:30PM	Johnson & Johnson to Host Investor Conference Call on First-Quarter Results (Business Wire)
12:28PM	AbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson (Benzinga)
08:39AM	4 Large-Cap Pharma Stocks to Watch as Industry Recovery Gains Steam (Zacks)
Mar-01-26 04:16AM	Oric Pharmaceuticals Teases Key 2026 Catalysts, Phase 3 Plans for Prostate and Lung Cancer Drugs (MarketBeat)
Feb-27-26 05:45PM	Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors (Zacks)
04:30PM	These Stocks Lead Dow Jones In February. Hint: It's Not AI Companies. (Investor's Business Daily)
10:02AM	J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? (Zacks)
Feb-26-26 02:30PM	Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer (PR Newswire)
11:21AM	A Decade From Now, You'll Regret Not Buying This 1 Small-Cap Stock (Barchart)
Feb-25-26 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
08:49AM	Can J&J Sustain Its Double-Digit Oncology Growth Streak? (Zacks)
06:20AM	Quantum Surgical buys J&Js NeuWave (MedTech Dive)
Feb-24-26 04:03PM	Johnson & Johnson seeks FDA approval of IMAAVY (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA) (PR Newswire)
02:36PM	2026 Stock Market Crash Coming? 3 Best ETFs to Protect You Now (24/7 Wall St.)
09:30AM	Wall Street Bulls Look Optimistic About Johnson & Johnson (JNJ): Should You Buy? (Zacks)
08:43AM	Operational Security Solutions (OSS) Partners With J&J Merchant Services to Expand Capital Access and Compliant Payment Infrastructure for Highly Regulated Industries (NewMediaWire)
08:01AM	Is Johnson & Johnson Stock Outperforming the Nasdaq? (Barchart)
06:16AM	Bayer Sues J&J Over 51% Claim (GuruFocus.com)
05:45AM	J&J Eyes Mega Sale Of DePuy Synthes In Orthopedics Breakup Push (Benzinga)
Feb-23-26 04:10PM	Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J (Investor's Business Daily)
01:11PM	Bloomberg Reports Potential Major Asset Sale by Johnson & Johnson (JNJ) (Insider Monkey)
11:09AM	Bayer sues Johnson & Johnson over marketing of prostate cancer drug (Reuters)
09:53AM	Stock Market Today: Dow Up After New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage) (Investor's Business Daily)
08:46AM	Stock Market Today: Dow Falls On New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage) (Investor's Business Daily)
08:44AM	Gilead Bets Big On Anito-Cel With $7.8 Billion Arcellx Deal (Investor's Business Daily)
08:13AM	Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs (Zacks)
Feb-21-26 11:31AM	FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer (Benzinga)
08:00AM	TREMFYA (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years (PR Newswire)
Feb-20-26 11:30AM	Why Is Johnson & Johnson (JNJ) Up 13% Since Last Earnings Report? (Zacks)
10:01AM	Johnson & Johnson Prepares Potential $20 Billion+ DePuy Sale (GuruFocus.com)
10:00AM	Johnson & Johnson Eyes Medtech Divestiture (GuruFocus.com)
08:16AM	Will Immunology Drugs Continue to Drive AbbVie's Top Line in 2026? (Zacks)
07:47AM	American Express, Deere Drop Board Diversity Criteria as 78% Disclosure Rate Falls (GuruFocus.com)
06:53AM	J&J Eyes Mega Sale Of DePuy Synthes In Orthopedics Breakup Push (Benzinga)
05:23AM	Madrigal sees a stock sell-off; ex-Novartis exec heads to Daiichi (BioPharma Dive)
Feb-19-26 06:30PM	Corporate giants retreat from board diversity mandates, Bloomberg reports (Investing.com)
05:00PM	RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer (PR Newswire)
02:49PM	Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports (Reuters)
02:16PM	J&J Explores $20 Billion-Plus Sale of Orthopedics Unit (Bloomberg)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Decker Robert J	VP Corporate Controller	Feb 27 '26	Option Exercise	115.67	4,075	471,355	27,757	Mar 03 04:21 PM
Decker Robert J	VP Corporate Controller	Feb 27 '26	Sale	247.87	4,075	1,010,070	23,682	Mar 03 04:21 PM
Decker Robert J	Officer	Feb 27 '26	Proposed Sale	247.87	4,075	1,010,070		Feb 27 02:35 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 20 '26	Sale	245.66	1,322	324,763	25,447	Feb 23 05:20 PM
Schmid Timothy	Officer	Feb 20 '26	Proposed Sale	245.66	1,322	324,763		Feb 20 10:46 AM
Swanson James D.	EVP, CIO	Feb 13 '26	Option Exercise	132.73	51,418	6,824,543	47,211	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 17 '26	Option Exercise	164.62	20,521	3,378,167	46,219	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 15 '26	Option Exercise	0.00	1,201	0	26,007	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 13 '26	Sale	243.73	41,559	10,129,312	25,020	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 17 '26	Sale	242.70	20,521	4,980,447	25,698	Feb 18 09:12 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '26	Option Exercise	0.00	1,241	0	114,613	Feb 18 09:12 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '26	Option Exercise	0.00	14,357	0	120,096	Feb 18 09:12 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '26	Option Exercise	0.00	994	0	20,081	Feb 18 09:12 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '26	Option Exercise	0.00	4,012	0	20,286	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 17 '26	Option Exercise	126.65	64,693	8,193,223	72,347	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '26	Option Exercise	0.00	3,849	0	39,778	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '26	Option Exercise	0.00	39,242	0	51,463	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 17 '26	Sale	242.80	89,654	21,767,827	14,000	Feb 18 09:12 PM
Decker Robert J	VP Corporate Controller	Feb 15 '26	Option Exercise	0.00	683	0	23,777	Feb 18 09:12 PM
Decker Robert J	VP Corporate Controller	Feb 13 '26	Option Exercise	0.00	3,053	0	23,950	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 17 '26	Option Exercise	156.89	51,648	8,103,281	42,868	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '26	Option Exercise	0.00	3,196	0	13,469	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 17 '26	Sale	243.00	53,931	13,105,233	10,658	Feb 18 09:12 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 15 '26	Option Exercise	0.00	2,024	0	24,112	Feb 18 09:11 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 13 '26	Option Exercise	0.00	14,357	0	29,591	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '26	Option Exercise	0.00	3,441	0	195,396	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '26	Option Exercise	0.00	28,714	0	206,318	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '26	Option Exercise	121.17	22,623	2,741,335	40,394	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '26	Option Exercise	0.00	2,054	0	27,217	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '26	Option Exercise	0.00	4,877	0	26,994	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '26	Sale	244.33	22,623	5,527,506	26,769	Feb 18 09:11 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '26	Option Exercise	0.00	8,187	0	326,407	Feb 18 09:11 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '26	Option Exercise	0.00	76,523	0	351,501	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '26	Option Exercise	0.00	1,018	0	29,470	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '26	Option Exercise	0.00	9,002	0	32,452	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 17 '26	Sale	243.39	6,197	1,508,288	23,003	Feb 18 09:11 PM
Schmid Timothy	Officer	Feb 18 '26	Proposed Sale	244.33	22,623	5,527,546		Feb 18 11:14 AM
Broadhurst Vanessa	Officer	Feb 17 '26	Proposed Sale	243.39	6,197	1,508,300		Feb 17 04:10 PM
Swanson James D.	Officer	Feb 17 '26	Proposed Sale	242.70	20,521	4,980,510		Feb 17 02:52 PM
Wolk Joseph J	Officer	Feb 17 '26	Proposed Sale	242.80	89,654	21,767,965		Feb 17 02:43 PM
REED JOHN C	Officer	Feb 17 '26	Proposed Sale	243.00	53,931	13,105,233		Feb 17 12:44 PM
Swanson James D.	Officer	Feb 13 '26	Proposed Sale	243.73	41,559	10,129,246		Feb 13 02:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 06 '26	Option Exercise	101.87	15,571	1,586,218	32,460	Feb 10 09:46 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 06 '26	Option Exercise	101.87	5,625	573,019	19,744	Feb 09 07:42 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 06 '26	Option Exercise	101.87	38,945	3,967,327	133,226	Feb 09 07:40 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 05 '26	Option Exercise	129.51	8,921	1,155,359	21,774	Feb 06 05:46 PM
Forminard Elizabeth	Officer	Feb 05 '26	Proposed Sale	237.90	6,226	1,481,195		Feb 05 04:31 PM
Duato Joaquin	CEO and Chairman of the Board	Jan 26 '26	Sale	221.23	100,000	22,122,893	30,852	Jan 28 06:07 PM
Joaquin Duato	CEO, Chariman	Jan 26 '26	Proposed Sale	220.14	100,000	22,014,000		Jan 26 04:57 PM
MORIKIS JOHN G	Director	Nov 26 '25	Buy	206.15	1,250	257,688	1,849	Dec 01 04:15 PM
JOHNSON & JOHNSON	10% Owner	Nov 26 '25	Sale	10.03	6,337	63,560	4,040,861	Dec 01 04:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 24 '25	Sale	10.06	2,200	22,132	4,047,198	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 21 '25	Sale	10.00	500	5,000	4,049,398	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 12 '25	Sale	10.00	1,000	10,000	4,049,898	Nov 14 03:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 06 '25	Sale	10.21	52,332	534,310	4,051,098	Nov 10 03:28 PM
JOHNSON & JOHNSON	10% Owner	Nov 07 '25	Sale	10.00	200	2,000	4,050,898	Nov 10 03:28 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Option Exercise	157.92	21,721	3,430,180	32,379	Oct 20 07:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Sale	192.71	21,721	4,185,793	10,658	Oct 20 07:13 PM
REED JOHN C	Officer	Oct 17 '25	Proposed Sale	192.71	21,721	4,185,794		Oct 17 10:23 AM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Option Exercise	101.87	56,471	5,752,701	234,484	Sep 05 06:00 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Sale	177.81	56,471	10,040,883	178,013	Sep 05 06:00 PM
Taubert Jennifer L	Officer	Sep 04 '25	Proposed Sale	177.81	56,471	10,040,904		Sep 04 02:37 PM
Forminard Elizabeth	Executive VP, General Counsel	Aug 29 '25	Option Exercise	115.67	11,521	1,332,634	22,423	Sep 03 05:13 PM
Forminard Elizabeth	Officer	Aug 29 '25	Proposed Sale	177.20	9,570	1,695,806		Aug 29 03:36 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Option Exercise	101.87	125,824	12,817,691	401,791	Aug 25 07:12 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Sale	179.21	125,824	22,548,655	275,967	Aug 25 07:12 PM
Duato Joaquin	Officer	Aug 22 '25	Proposed Sale	180.03	125,824	22,652,724		Aug 22 01:58 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Option Exercise	101.87	16,820	1,713,453	30,820	Aug 18 06:19 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Sale	176.91	16,820	2,975,571	14,000	Aug 18 06:19 PM
Wolk Joseph J	Officer	Aug 15 '25	Proposed Sale	176.91	16,820	2,975,571		Aug 15 03:57 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Jul 17 '25	Sale	163.55	19,137	3,129,830	10,658	Jul 18 04:12 PM
REED JOHN C	Officer	Jul 17 '25	Proposed Sale	163.55	19,137	3,129,831		Jul 17 04:05 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '25	Option Exercise	0.00	25,255	0	40,797	May 05 05:10 PM

Open in Screener

SHW

Sherwin-Williams Co

Apr 02 • 04:00PM ET

318.00

-7.70 -2.36 %

Basic Materials • Specialty Chemicals • USA • NYSE

SHW Sherwin-Williams Co daily Stock Chart

Peers: PPG RPM AXTA ECL HUN FMC CC VAL IFF NUE

| Held by: VTI VOO DIA VUG IVV SPY VIG XLB IWF VAW

Index	DJIA, S&P 500	P/E	30.99	EPS (ttm)	10.26	Insider Own	7.33%	Shs Outstand	247.70M	Perf Week	-0.49%
Market Cap	78.79B	Forward P/E	23.78	EPS next Y	13.37	Insider Trans	-0.03%	Shs Float	229.61M	Perf Month	-8.53%
Enterprise Value	92.54B	PEG	2.43	EPS next Q	2.28	Inst Own	82.58%	Short Float	2.00%	Perf Quarter	-1.86%
Income	2.57B	P/S	3.34	EPS this Y	3.55%	Inst Trans	-1.13%	Short Ratio	2.51	Perf Half Y	-6.80%
Sales	23.57B	P/B	17.13	EPS next Y	13.00%	ROA	10.37%	Short Interest	4.58M	Perf YTD	-1.86%
Book/sh	18.56	P/C	380.27	EPS next 5Y	9.79%	ROE	59.39%	52W High	379.65 -16.24%	Perf Year	-10.08%
Cash/sh	0.84	P/FCF	29.69	EPS past 3/5Y	9.95% 6.86%	ROIC	15.60%	52W Low	301.58 5.44%	Perf 3Y	41.48%
Dividend Est.	3.07 (0.97%)	EV/EBITDA	20.15	Sales past 3/5Y	2.10% 5.12%	Gross Margin	48.85%	Volatility	2.71% 2.73%	Perf 5Y	27.33%
Dividend TTM	3.17 (1.00%)	EV/Sales	3.93	EPS Y/Y TTM	-2.88%	Oper. Margin	16.61%	ATR (14)	9.50	Perf 10Y	231.65%
Dividend Ex-Date	Mar 02, 2026	Quick Ratio	0.53	Sales Y/Y TTM	2.06%	Profit Margin	10.90%	RSI (14)	42.58	Recom	1.89
Dividend Gr. 3/5Y	9.60% 12.04%	Current Ratio	0.87	EPS Q/Q	1.07%	SMA20	-0.44%	Beta	1.25	Target Price	388.00
Payout	30.81%	Debt/Eq	3.03	Sales Q/Q	5.64%	SMA50	-7.19%	Rel Volume	0.97	Prev Close	325.70
Employees	64249	LT Debt/Eq	2.58	Earnings	Jan 29 BMO	SMA200	-7.39%	Avg Volume	1.83M	Price	318.00
IPO	Jul 02, 1962	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.27% 0.55%	Trades		Volume	1,767,999	Change	-2.36%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-23-26	Downgrade	Deutsche Bank	Buy → Hold	$380
Jan-07-26	Upgrade	Vertical Research	Hold → Buy	$371
Dec-18-25	Upgrade	Citigroup	Neutral → Buy	$390
Aug-14-25	Upgrade	BofA Securities	Underperform → Neutral	$375
Jun-13-25	Downgrade	Citigroup	Buy → Neutral	$385
Mar-10-25	Downgrade	Jefferies	Buy → Hold	$423 → $380
Feb-26-25	Resumed	Citigroup	Buy	$418 → $423
Jan-24-25	Upgrade	Berenberg	Hold → Buy	$321 → $420
Oct-07-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jul-24-24	Reiterated	Evercore ISI	Outperform	$360 → $365
Apr-25-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$400
Mar-07-24	Upgrade	UBS	Neutral → Buy	$312 → $402
Mar-01-24	Initiated	Wolfe Research	Peer Perform
Feb-27-24	Upgrade	Northcoast	Neutral → Buy	$360
Jan-08-24	Downgrade	Seaport Research Partners	Buy → Neutral
Jan-03-24	Downgrade	Robert W. Baird	Outperform → Neutral	$270 → $300
Jan-02-24	Downgrade	Northcoast	Buy → Neutral	$315
Oct-18-23	Downgrade	BofA Securities	Neutral → Underperform	$300 → $275
Jun-26-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$269 → $275
Jun-14-23	Initiated	Citigroup	Buy	$283

Show Previous Ratings

Apr-01-26 08:00AM	Sherwin-Williams to Announce First Quarter 2026 Financial Results on April 28, 2026 (PR Newswire)
Mar-18-26 10:33AM	Retailers and materials companies are under pressure on Wednesday after a hot wholesale inflation report (MarketWatch)
Mar-12-26 02:22PM	Is PPG Industries Stock Outperforming the S&P 500? (Barchart)
09:00AM	The Sherwin-Williams Company to Hold Financial Community Presentation on September 24, 2026 (PR Newswire)
Mar-11-26 10:00AM	Dow Jones drops but Oracle lifts S&P and Nasdaq as Gulf shipping attacks eyed (Proactive)
01:50PM	Loading…
Mar-07-26 01:50PM	Dow Jones Movers: IBM Leads, Sherwin-Williams Drags as Analysts Clash on Salesforce (24/7 Wall St.)
Mar-05-26 11:35AM	Here Are the Stocks Dragging the Dow Lower (The Wall Street Journal)
Mar-03-26 07:06PM	Analyst Report: The Sherwin-Williams Company (Morningstar Research)
10:33AM	Dow and Nasdaq plunge 2% as Amazon data centres hit in Iran war (Proactive)
09:55AM	Dow Jones opens 1,000 points lower amid widespread selling sparked by Iran war (Proactive)
Mar-02-26 12:43PM	Stock Market Today: Nasdaq Up After U.S.-Iran Attacks; LNG Stock Clears Entry As Oil Prices Pop (Live Coverage) (Investor's Business Daily)
11:44AM	Stock Market Today: Dow Off Lows After U.S.-Iran Attacks; Oil Stocks Jump, Fertilizer Play Does This (Live Coverage) (Investor's Business Daily)
10:00AM	Dow Jones leads modest retreat as Wall Street aloof to Iran war (Proactive)
Feb-27-26 07:47AM	How Is Sherwin-Williams Stock Performance Compared to Other Basic Materials Stocks? (Barchart)
Feb-20-26 06:13PM	Mizuho Raises Sherwin-Williams (SHW) Price Target to $410 after Earnings Review (Insider Monkey)
11:05PM	Loading…
Feb-18-26 11:05PM	3 Reasons to Sell SHW and 1 Stock to Buy Instead (StockStory)
04:02PM	The bullish breakout in these stocks suggests the housing market has turned a corner (MarketWatch)
01:18PM	Sherwin-Williams Declares Dividend of $0.80 per Common Share (PR Newswire)
Feb-13-26 08:35PM	Analyst Report: The Sherwin-Williams Company (Morningstar Research)
Feb-10-26 07:55PM	Review & Preview: Consumers Show Strain (Barrons.com)
12:56PM	Is Wall Street Bullish or Bearish on Sherwin-Williams Stock? (Barchart)
Feb-08-26 09:44AM	The Dow Surged Past 50,000. How It Got There, and Where It Goes Next. (Barrons.com)
Feb-06-26 04:15PM	The Dow Industrials Have Tilted More Toward Financials (The Wall Street Journal)
01:53PM	The Dow Is on the Verge of 50,000. It's Not About Tech. (Barrons.com)
Feb-05-26 12:38AM	Sherwin-Williams's Q4 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Feb-02-26 10:53AM	Analyst Report: The Sherwin-Williams Company (Morningstar Research)
Jan-30-26 08:04AM	Company News for Jan 30, 2026 (Zacks)
02:08AM	Sherwin-Williams Q4 Earnings Call Highlights (MarketBeat)
12:35AM	SHW Q4 Deep Dive: Stable Margins Amid Choppy End Markets and Realistic 2026 Outlook (StockStory)
Jan-29-26 04:06PM	Sherwin-Williams Co (SHW) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Growth ... (GuruFocus.com)
12:26PM	Loading…
12:26PM	Sherwin-Williams Warns 2026 Housing Demand Is 'Hard To Predict' (Benzinga)
10:52AM	Sherwin-Williams Stock Slips. Earnings Paint a Grim Picture of Customer Spending. (Barrons.com)
10:50AM	Sherwin-Williams' Q4 Earnings and Revenues Surpass Estimates (Zacks)
10:00AM	Sherwin-Williams (SHW) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:37AM	Sherwin-Williams's (NYSE:SHW) Q4 CY2025: Beats On Revenue (StockStory)
08:15AM	Sherwin-Williams (SHW) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:17AM	Sherwin-Williams: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	The Sherwin-Williams Company Reports 2025 Year-End and Fourth Quarter Financial Results (PR Newswire)
02:57AM	Zacks Value Investor Highlights: The Sherwin-Williams, Berkshire, Bank of America (Zacks)
Jan-28-26 01:00PM	Top Lessons from Rich 95-Year-Old Stock Investors (Zacks)
Jan-27-26 10:12PM	Sherwin-Williams (SHW) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jan-26-26 09:15AM	Curious about Sherwin-Williams (SHW) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Jan-25-26 07:52AM	Big Tech earnings, Fed meeting feature as markets end January with busiest week of Q1: What to watch (Yahoo Finance)
Jan-24-26 09:00AM	Deutsche Bank downgrades Sherwin-Williams to Hold on valuation (TipRanks)
Jan-23-26 04:34PM	Stocks Finish Mostly Higher Despite a Plunge in Intel (Barchart)
11:24AM	Stocks Recover on Strength in Megacap Tech and Consumer Sentiment (Barchart)
09:57AM	Stocks Pressured by Weakness in Chip Makers (Barchart)
09:41AM	Darden upgraded, Trade Desk downgraded: Wall Street's top analyst calls (The Fly)
09:01AM	Citi Maintains Buy Rating for Sherwin-Williams (SHW) (Insider Monkey)
Jan-22-26 10:00AM	Sherwin-Williams (SHW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jan-21-26 11:04PM	Sherwin-Williams (SHW): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Jan-05-26 08:00AM	Sherwin-Williams to Announce Fourth Quarter and Full Year 2025 Financial Results on January 29, 2026 (PR Newswire)
Dec-30-25 06:03AM	Sherwin-Williams Earnings Preview: What to Expect (Barchart)
Dec-20-25 04:50PM	Is Sherwin-Williams Still a Buy After Its 115,000% Run? (Motley Fool)
Dec-11-25 10:05AM	Dow Is on Track for a Record Level (Barrons.com)
10:04AM	Stock Market Today: Dow Rises On Jobs Data; ATI Moves Past Entry As Oracle Plunges On Earnings (Live Coverage) (Investor's Business Daily)
Dec-09-25 01:21PM	Stocks Pause Ahead of Fed Decision on Rates (Barrons.com)
Dec-08-25 10:53AM	Top-Ranked ETFs to Power Your Portfolio Higher (Zacks)
Dec-04-25 11:30AM	Ashland (ASH) Up 14.9% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-27-25 11:30AM	Why Is Sherwin-Williams (SHW) Down 0.7% Since Last Earnings Report? (Zacks)
Nov-25-25 09:14AM	Sherwin-Williams Stock: Is SHW Underperforming the Basic Materials Sector? (Barchart)
Nov-24-25 02:03PM	Stock Market Today: Nasdaq Surges On Tech Spike; These Defense Stocks Fall Amid Ukraine Progress (Live Coverage) (Investor's Business Daily)
Nov-21-25 04:32PM	Stock Market Today: Dow Gains Nearly 500 Points After Whipsaw Action As Nvidia Finishes Lower (Live Coverage) (Investor's Business Daily)
03:27PM	Stock Market Today: Dow Rallies In Final Hours; Eli Lilly Hits Milestone, Joins Elite Group (Live Coverage) (Investor's Business Daily)
12:35PM	Stock Market Today: Dow Soars 700 Points; Nvidia Climbs Off Lows After Earnings Carnage (Live Coverage) (Investor's Business Daily)
Nov-14-25 10:58AM	Stock Market Today: Dow Jones Plunges 300 Points, But Nvidia, Palantir Recover Early Losses (Live Coverage) (Investor's Business Daily)
Nov-13-25 10:32PM	Winners And Losers Of Q3: Sherwin-Williams (NYSE:SHW) Vs The Rest Of The Building Materials Stocks (StockStory)
Nov-12-25 07:59AM	Are Wall Street Analysts Bullish on Sherwin-Williams Stock? (Barchart)
Nov-08-25 12:39AM	Mizuho Lifts Sherwin-Williams (SHW) Price Target to $400 After Solid Q3 Results (Insider Monkey)
Nov-07-25 07:22PM	Rates dropping will unlock renovation cycle, says Obermeyer's Ali Flynn Phillips on Sherwin-Williams (CNBC TV)
04:41PM	Stock Market Today: Dow, S&P 500 Eke Out Gains; Palantir, Nvidia Close Higher (Live Coverage) (Investor's Business Daily)
03:27PM	Stock Market Today: Dow Flirts With Positive Territory; Palantir Reverses Higher (Live Coverage) (Investor's Business Daily)
02:18PM	Stock Market Today: Dow, Nasdaq Trim Losses In Final Hours; Nvidia, Palantir Improve (Live Coverage) (Investor's Business Daily)
Nov-04-25 07:17PM	Analyst Report: The Sherwin-Williams Company (Morningstar Research)
12:36AM	5 Must-Read Analyst Questions From Sherwin-Williams's Q3 Earnings Call (StockStory)
Nov-03-25 11:53PM	Citi Raises Sherwin-Williams' (SHW) Price Target Following Strong Q3 Performance (Insider Monkey)
04:15PM	Sherwin-Williams Board of Directors Elects Benjamin E. Meisenzahl as CFO Effective January 1, 2026 (PR Newswire)
09:18AM	What I Wish I Had Known Before Creating My Own Investing Blueprint (Motley Fool)
Nov-02-25 07:35PM	Dividend Stocks That Can Help You Become a Millionaire (Motley Fool)
Oct-30-25 03:16PM	Sherwin-Williams Co (SHW) Q3 2025 Earnings Call Highlights: Strong Sales and Strategic ... (GuruFocus.com)
08:02AM	Honeywell completes spinoff of Solstice Advanced Materials (Manufacturing Dive)
Oct-29-25 01:32AM	SHW Q3 Deep Dive: Share Gains and Cost Controls Offset Ongoing Market Weakness (StockStory)
Oct-28-25 05:01PM	Stock Market Today: Dow Ends At Record High; Nvidia Surges As Microsoft Hits Rare Milestone (Live Coverage) (Investor's Business Daily) +5.47%
03:41PM	Stock Market Today: Nasdaq Jumps As Microsoft Hits $4 Trillion Mark; Biotech Name Leaps (Live Coverage) (Investor's Business Daily)
02:02PM	Stock Market Today: Dow Up 300 Points As Microsoft Joins $4 Trillion Club; Cruise Stock Sinks (Live Coverage) (Investor's Business Daily)
01:57PM	Sherwin-Williams Q3 Earnings & Revenues Surpass Estimates (Zacks)
01:20PM	Sherwin-Williams, Microsoft and UnitedHealth are pushing the Dow to intraday high (MarketWatch)
12:31PM	Stock Market Today: Dow Hits High As Fed Meets; Microsoft Joins Nvidia In $4 Trillion Club (Live Coverage) (Investor's Business Daily)
12:11PM	Why Sherwin-Williams (SHW) Stock Is Trading Up Today (StockStory)
11:49AM	Top Stock Movers Now: PayPal, UPS, F5, and More (Investopedia)
10:37AM	The Dow is outpacing the other indexes today, thanks to these two companies (MarketWatch)
09:30AM	Compared to Estimates, Sherwin-Williams (SHW) Q3 Earnings: A Look at Key Metrics (Zacks)
08:28AM	Sherwin-Williams (NYSE:SHW) Beats Q3 Sales Expectations, Stock Soars (StockStory)
08:10AM	Sherwin-Williams (SHW) Tops Q3 Earnings and Revenue Estimates (Zacks)
07:39AM	Sherwin-Williams' Profit Higher as Same-Store Sales Rise (The Wall Street Journal)
07:07AM	Sherwin-Williams: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	The Sherwin-Williams Company Reports 2025 Third Quarter Financial Results (PR Newswire)
Oct-27-25 11:54AM	Wells Fargo Cuts Sherwin-Williams (SHW) PT, Keeps Overweight Rating (Insider Monkey)
Oct-26-25 11:11PM	Earnings To Watch: Sherwin-Williams (SHW) Reports Q3 Results Tomorrow (StockStory)
07:43AM	Big Tech earnings, a crucial Fed meeting, and a Trump-Xi sit-down: What to watch this week (Yahoo Finance)

The Sherwin-Williams Co. engages in the development, manufacture, distribution, and sale of paint and coatings. It operates through the following segments: Paint Stores Group, Consumer Brands Group, Performance Coatings Group, and Administrative. The Paint Stores Group segment caters to the needs of architectural and industrial paint contractors and do-it-yourself homeowners. The Consumer Brands Group segment manufactures and distributes a broad portfolio of branded and private-label architectural paint, stains, varnishes and other industrial products. The Performance Coatings Group segment develops and sells industrial coatings for wood finishing and general industrial applications. The Administrative segment refers to the administrative expenses and assets of the company's new global headquarters and research and development center, both currently under construction. The company was founded by Henry Sherwin and Edward Williams in 1866 and is headquartered in Cleveland, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Young Bryan J	SVP - Corp Strategy & Devel.	Feb 24 '26	Sale	364.47	2,513	915,913	10,045	Feb 25 05:38 PM
Young Bryan J	Officer	Feb 24 '26	Proposed Sale	364.47	2,513	915,913		Feb 24 10:40 AM
Davie Colin M.	Pres. & GM, Glob. Supply Chain	Feb 02 '26	Option Exercise	127.98	2,976	380,868	8,341	Feb 04 05:54 PM
Davie Colin M.	Pres. & GM, Glob. Supply Chain	Feb 02 '26	Sale	359.50	2,976	1,069,872	5,365	Feb 04 05:54 PM
Davie Colin M.	Officer	Feb 02 '26	Proposed Sale	359.55	2,976	1,070,034		Feb 02 01:38 PM
Mistysyn Allen J	SVP - Finance & CFO	Dec 01 '25	Option Exercise	249.11	802	199,788	13,562	Dec 03 06:20 PM
Binns Justin T	President, Glob. Architectural	Aug 25 '25	Option Exercise	79.85	609	48,629	18,531	Aug 27 04:35 PM
Binns Justin T	President, Glob. Architectural	Aug 25 '25	Sale	368.82	609	224,611	17,922	Aug 27 04:35 PM
Binns Justin T	Officer	Aug 25 '25	Proposed Sale	368.82	609	224,612		Aug 25 10:22 AM
Lang James P.	SVP - Enterprise Finance & CAO	Aug 06 '25	Option Exercise	186.85	860	160,691	1,237	Aug 08 08:05 AM
Lang James P.	SVP - Enterprise Finance & CAO	Aug 06 '25	Sale	350.35	860	301,301	377	Aug 08 08:05 AM
Lang James P.	Officer	Aug 06 '25	Proposed Sale	350.35	860	301,301		Aug 06 11:56 AM
Rea Todd D	President, Consumer Brands Grp	Jun 06 '25	Option Exercise	236.64	2,686	635,628	13,552	Jun 10 04:07 PM
Rea Todd D	President, Consumer Brands Grp	Jun 06 '25	Sale	359.16	4,223	1,516,733	9,329	Jun 10 04:07 PM
Rea Todd D	Officer	Jun 06 '25	Proposed Sale	359.16	4,223	1,516,745		Jun 06 04:17 PM

JNJ

Johnson & Johnson

SHW

Sherwin-Williams Co

Upgrade your Finviz experience